Published in J Clin Immunol on January 01, 1991
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States. J Clin Microbiol (1992) 0.98
Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children. Viral Immunol (2011) 0.78
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes. Clin Exp Immunol (1994) 0.77
Evidence of simian virus 40 exposure in a colony of captive baboons. Virology (2008) 0.77
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study. BMC Infect Dis (2017) 0.75
Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. Clin Diagn Lab Immunol (1995) 0.75
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
A waterborne outbreak of cryptosporidiosis in normal hosts. Ann Intern Med (1985) 5.27
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci (1988) 5.00
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol (1987) 4.12
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79. Int J Epidemiol (2007) 3.13
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies. Med Phys (1999) 2.64
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements. Med Phys (1999) 2.29
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol (2013) 2.25
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology (1993) 2.20
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17
Nosocomial Legionnaires' disease: aspiration as a primary mode of disease acquisition. Am J Med (1993) 2.08
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05
Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals. Mol Cell Biol (1989) 1.97
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Dose reduction in computed tomography by attenuation-based on-line modulation of tube current: evaluation of six anatomical regions. Eur Radiol (2000) 1.93
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol (1992) 1.86
Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses (1998) 1.83
E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J Virol (1998) 1.83
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol (2001) 1.81
Effect of basic and nonbasic amino acid substitutions on transport induced by simian virus 40 T-antigen synthetic peptide nuclear transport signals. Mol Cell Biol (1988) 1.80
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (1989) 1.80
Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med (1993) 1.79
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology (2000) 1.77
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest (1989) 1.77
Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77
Persistence of Epstein-Barr virus in the parotid gland. J Virol (1984) 1.75
In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.69
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
PCR-based detection of mycobacteria in sputum samples using a simple and reliable DNA extraction protocol. Biotechniques (1994) 1.63
Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes. Eur J Biochem (1977) 1.63
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60
Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol (1998) 1.60
Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci U S A (1980) 1.59
Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol (1989) 1.58
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol (1995) 1.57
Specific and sensitive two-step polymerase chain reaction assay for the detection of Salmonella species. Eur J Clin Microbiol Infect Dis (1996) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Purification and properties of Herpesvirus saimiri DNA. Virology (1974) 1.55
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci U S A (1997) 1.55
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
Dose reduction in CT by on-line tube current control: principles and validation on phantoms and cadavers. Eur Radiol (1999) 1.53
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther (2000) 1.52
Polymer-supported bilayer on a solid substrate. Biophys J (1992) 1.50
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res (1997) 1.49
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
[Assessment of late pregnancy terminations, 2004-2007]. Ned Tijdschr Geneeskd (2008) 1.45
Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J Virol (1997) 1.44
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect (1979) 1.43
Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med (1996) 1.43
[Pyelonephritis during pregnancy: a threat to mother and child]. Ned Tijdschr Geneeskd (2007) 1.42
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor. Eur J Biochem (1977) 1.41
[The Vancouver rules and the scientific ethical committee system]. Ugeskr Laeger (2001) 1.39
Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38
[Late postpartum eclampsia]. Ned Tijdschr Geneeskd (2007) 1.38
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (1975) 1.35
Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem (1999) 1.33
Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches. Eur J Immunol (1996) 1.33
Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol (1999) 1.31
Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus. J Virol (1986) 1.31
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res (1996) 1.29